New yellow fever vaccine passes safety check in 640 adults

NCT ID NCT07002060

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times

Summary

This study tested a new yellow fever vaccine (vYF) to see if it is as safe as the current licensed vaccine (YF-VAX). A total of 640 healthy adults aged 18 to 60 received a single shot of either the new or the existing vaccine. Researchers monitored side effects like pain, fever, and headache for 6 months to compare safety between the two groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for YELLOW FEVER IMMUNIZATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • J. Lewis Research, Inc. / Foothill Family Clinic

    Salt Lake City, Utah, 84109, United States

  • Johns Hopkins Bloomberg School of Public Health- Site Number : 8400009

    Baltimore, Maryland, 21205, United States

  • Rochester Clinical Research- Site Number : 8400005

    Rochester, New York, 14610, United States

  • Saint Louis University Center for Vaccine Development- Site Number : 8400001

    St Louis, Missouri, 63104, United States

  • The Hope Clinic of Emory University- Site Number : 8400006

    Decatur, Georgia, 30030, United States

  • Velocity Clinical Research - Providence- Site Number : 8400003

    East Greenwich, Rhode Island, 02818, United States

  • Velocity Clinical Research-New Orleans- Site Number : 8400004

    New Orleans, Louisiana, 70119, United States

Conditions

Explore the condition pages connected to this study.